pro medicus - PMDIY

PMDIY

Close Chg Chg %
18.99 -0.44 -2.29%

Closed Market

18.55

-0.44 (2.29%)

Volume: 2.23K

Last Updated:

Feb 19, 2026, 3:47 PM EDT

Company Overview: pro medicus - PMDIY

PMDIY Key Data

Open

$19.48

Day Range

16.00 - 19.48

52 Week Range

16.00 - 45.75

Market Cap

$8.72B

Shares Outstanding

522.35M

Public Float

N/A

Beta

2.54

Rev. Per Employee

N/A

P/E Ratio

59.62

EPS

N/A

Yield

32.47%

Dividend

$0.04

EX-DIVIDEND DATE

Feb 27, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

300.41

 

PMDIY Performance

1 Week
 
-20.10%
 
1 Month
 
-31.26%
 
3 Months
 
-46.91%
 
1 Year
 
N/A
 
5 Years
 
N/A
 

PMDIY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Pro Medicus - PMDIY

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
67.79M 84.02M 105.84M 137.93M
Sales Growth
+33.91% +23.95% +25.97% +30.32%
Cost of Goods Sold (COGS) incl D&A
16.81M 21.89M 25.69M 28.38M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
5.31M 5.33M 5.58M 4.69M
Depreciation
589.66K 561.71K 555.10K 643.10K
Amortization of Intangibles
4.72M 4.77M 5.02M 4.04M
COGS Growth
+6.24% +30.18% +17.36% +10.49%
Gross Income
50.97M 62.13M 80.16M 109.55M
Gross Income Growth
+46.49% +21.90% +29.01% +36.67%
Gross Profit Margin
+75.20% +73.95% +75.73% +79.42%
2022 2023 2024 2025 5-year trend
SG&A Expense
5.73M 5.71M 6.59M 7.43M
Research & Development
- - - -
-
Other SG&A
5.72M 5.71M 6.59M 7.43M
SGA Growth
+79.31% -0.22% +15.37% +12.69%
Other Operating Expense
- - - -
-
Unusual Expense
1.69M 199.79K (701.91K) (63.47K)
EBIT after Unusual Expense
43.56M 56.22M 74.27M 102.19M
Non Operating Income/Expense
2.19M 1.72M 2.08M 3.58M
Non-Operating Interest Income
470.71K 1.64M 3.17M 4.90M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
45.75M 57.94M 76.35M 105.77M
Pretax Income Growth
+43.10% +26.64% +31.78% +38.53%
Pretax Margin
+67.49% +68.96% +72.13% +76.68%
Income Tax
13.52M 17.14M 22.09M 31.15M
Income Tax - Current - Domestic
13.42M 18.59M 23.23M 32.90M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
93.56K (1.46M) (1.14M) (1.75M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
32.23M 40.80M 54.26M 74.62M
Minority Interest Expense
- - - -
-
Net Income
32.23M 40.80M 54.26M 74.62M
Net Income Growth
+40.11% +26.57% +33.00% +37.52%
Net Margin Growth
+47.55% +48.56% +51.27% +54.10%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
32.23M 40.80M 54.26M 74.62M
Preferred Dividends
- - - -
-
Net Income Available to Common
32.23M 40.80M 54.26M 74.62M
EPS (Basic)
0.0618 1.9538 0.1039 0.1428
EPS (Basic) Growth
+39.82% +3,061.49% -94.68% +37.44%
Basic Shares Outstanding
521.57M 20.88M 522.20M 522.38M
EPS (Diluted)
0.0616 1.9504 0.1037 0.1426
EPS (Diluted) Growth
+40.00% +3,066.23% -94.68% +37.51%
Diluted Shares Outstanding
522.91M 20.92M 523.26M 523.31M
EBITDA
50.55M 61.75M 79.14M 106.81M
EBITDA Growth
+36.74% +22.15% +28.16% +34.96%
EBITDA Margin
+74.58% +73.50% +74.77% +77.44%

Pro Medicus in the News